The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
National Hypertension Association, Inc.
324 East 30th Street
New York, NY 10016
The National Hypertension Association, Inc., (NHA) is a non-profit organization dedicated to combating the chronic health problem of high blood pressure (hypertension) by developing, directing, and implementing effective programs to promote research, educate the public, and ensure prompt detection and effective treatment of hypertension. The NHA is committed to researching the causes of essential hypertension and enhancing the understanding of certain secondary types of hypertension through basic laboratory research studies, thereby improving treatment of these conditions; educating and alerting the public to the dangers of hypertension; informing physicians as well as medical students of the most current advances in its causes, diagnosis, treatment, and prevention; and detecting hypertension wherever it exists in the most economical and effective way. Established in 1977 by a group of concerned scientists, doctors, and philanthropists, NHA offers charitable blood pressure screening, provides work-site detection programs, and has a well-defined program of basic and clinical research to gain better insight into the causes of hypertension. Materials include brochures, pamphlets, a regular newsletter, reports, and information packets.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.